Date: 2013-06-06
Type of information: Development agreement
Compound: undisclosed
Company: Flamel Technologies (France) undisclosed pharmaceutical company
Therapeutic area: undisclosed
Type agreement: development
Action mechanism:
Disease: undisclosed
Details: * On June 6, 2013, Flamel Technologies has announced a multi-year development partnership agreement with an undisclosed, large international pharmaceutical company. The development work, which will be done in Flamel\'s Bordeaux facility, is expected to generate revenue of over $4 million over the next several years and has the potential for expansion.
Financial terms:
Latest news:
